Aim: The purpose of this study was to evaluate the efficacy of en bloc nephrectomy for perirenal retroperitoneal sarcoma (RPS) with respect to postoperative kidney function and oncological benefits.
INTRODUCTION
Retroperitoneal sarcoma (RPS) is a rare tumor with a mean annual incidence of approximately 2.7 cases per 10 6 persons. 1 Since RPS has a tendency to be locally advanced and involves adjacent organs and major vascular structures at presentation, 2 it is difficult to determine the optimal extent of surgery for complete resection of RPS. Retroperitoneal liposarcoma (LPS) originating from perinephric fat tissue is usually a huge mass that encases or abuts an adjacent kidney. Thus, there is an ongoing debate regarding the necessity to perform en bloc nephrectomy for complete surgical resection of perinephric RPS. Some surgeons claim that contiguous organ resection is safe and improves
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. loco-regional tumor control. [3] [4] [5] However, others oppose en bloc nephrectomy because of the potential long-term risk of chronic kidney disease (CKD) requiring dialysis and limitations in systemic chemotherapy. 6 There have been some reports regarding kidney function changes after nephrectomy performed for various reasons, including RPS. [7] [8] [9] To our knowledge, there have been no comparative studies that simultaneously analyzed oncological outcome and residual kidney function after en bloc nephrectomy for RPS compared with surgical resection without nephrectomy. We compared residual renal functional outcomes after nephrectomy as a part of extended surgery for RPS with the renal function of patients who underwent surgical resection Asia-Pac J Clin Oncol. 2018;14:e465-e471.
wileyonlinelibrary.com/journal/ajco e465 without nephrectomy and assessed progression of CKD stage in terms of renal adaptation. We also studied whether en bloc nephrectomy for RPS achieved a better oncological outcome through evaluation of local recurrence and cancer-specific survival compared to conventional excision of perirenal RPS without nephrectomy.
METHODS

Study design and population
After approval by the Institutional Review Board, all patients who underwent a primary operation for complete resection of RPS at a single institution between October 1996 and September 2015 were retrospectively analyzed. Over a 20-year period at our institute, 149 patients underwent primary surgical resection for RPS located in the perirenal space or with suspected ureter invasion. Exclusion criteria included no medical record of renal function test at least 30 days after surgery (n = 28), bilateral nephrectomy (n = 2), history of previous nephrectomy (n = 1), concomitant evidence of distant metastases (n = 2) and diagnosed with end-stage renal disease (ESRD) before surgery (n = 2). In total, 114 patients were included in this study.
The median follow-up duration of the studied cohort was 29 months 
Statistical analysis
The primary endpoint was residual renal function. We compared CKD stage progression between the NPX and no-NPX groups. We compared the proportion of CKD progression in NPX and no-NPX groups with the Chi-square test. The secondary endpoint was reduction of ultimate GFR to 60% or less of preoperative GFR based on residual renal adaptation after unilateral nephrectomy. Regarding oncologic outcomes, the primary endpoint of the study was incidence of local recurrence, and the secondary endpoint was cancer-specific survival.
Continuous data were represented as median and IQR. Categorical data were specified as numbers and percentages. Statistical analysis was conducted using independent-samples T or Mann-Whitney tests for continuous values and the Chi-square or Fisher's exact tests, especially when expected cell frequencies were below 5 for categorical values. The incidence of local recurrence and overall survival rate were analyzed by the Kaplan-Meier method. The log-rank test was used to compare curves produced from the NPX and no-NPX groups. A P value < 0.05 was considered statistically significant.
Data handling and analysis were carried out using Statistical Package for Social Sciences for Windows release 22.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Demographic, histological and treatment-associated characteristics of NPX and no-NPX groups
In the study cohort of 114 patients as shown in Table 1 , median age at operation was 57 years (IQR 49-64 years). Male to female proportion was 50:50, with 57 patients each. Tumors in the NPX group were significantly larger than those in the no-NPX group, as median tumor size was 26 and 12 cm, respectively (P < 0.001). The majority (73%) of tumors in both groups were high-grade RPS (FNCLCC grades 2 and 3), and 59 patients (89%) in the NPX group were diagnosed with LPS, whereas 28 patients (57%) in the no-NPX group were diagnosed with LPS (P < 0.001). Although there was no difference in macroscopic completeness of resection between the two groups, patients in the NPX group underwent statistically more contiguous organ resections (NPX:
35 cases [53%] vs no-NPX: 11 cases [22%], P = 0.002). The NPX group underwent more combined resection of adjacent organs such as the colon (P = 0.002), pancreas (P = 0.042) and spleen (P = 0.005) compared to the no-NPX group. Although chemotherapy was applied with no specific difference between the two groups, patients in the NPX group more frequently underwent tissue expander insertion (41% vs 16%, P = 0.004) and adjuvant radiation therapy (RT) (61% vs 37%, P = 0.011).
F I G U R E 1
Residual renal function changes between nephrectomy A and no nephrectomy B groups based on renal adaptation (60% of preoperative GFR)
Comparison of renal function changes after surgical resection between NPX and no-NPX groups
As shown in decreased remarkably in the NPX group compared to the no-NPX group (P = 0.001 and P = 0.001, respectively). As shown in Figure 1 , there were 35patients (54%) in the NPX group and 12 patients (25%) in the no-NPX group with ultimate GFR reduced to75% or less of preoperative GFR as the cutoff value. Maintenance of GFR after unilateral nephrectomy has been reported as 60-75% of prenephrectomy GFR. 14 There were 16 (25%) patients in the NPX group and 5 (10%) patients in the no-NPX group with ultimate GFR reduced to 60% or less of preoperative GFR. In terms of renal adaptation, there was no statistical difference between the two groups in decline of ultimate GFR (P = 0.086).
Progression of CKD stage and residual renal function in terms of renal adaptation
Local recurrence and cancer-specific survival
This analysis was applied in 84 patients (74%) who underwent complete macroscopic resection in the total cohort of 114 patients. Median follow-up duration for survival was 36 months (IQR 20-69 months).
The 5-year cumulative incidence of local recurrence for the 84 studied patients was not different between the NPX and no-NPX groups (P = 0.429; FIGURE 2A). Subgroup analysis according to FNCLCC grade showed the 5-year local recurrence rate for grade 2 patients in the NPX group was 55%, whereas it was 63% for those in the no-NPX group.
This difference was statistically significant (P = 0.048; Figure 2C ). However, the 5-year local recurrence rate for grade 1 and grade 3 patients
was not different between the NPX and no-NPX groups (P=0.4560; FIGURE 2B and P=0.5418; FIGURE 2D, respectively).
The 5-year cancer-specific survival rates in the NPX and no-NPX groups were 75% and 71%, respectively (P = 0.554). Subgroup analysis of FNCLCC grade 2 showed the 5-year cancer-specific survival for 25 patients who underwent en bloc nephrectomy was 88%, compared with 43% for 19 patients in the no-NPX group. There was a trend toward better cancer-specific survival for grade 2 tumors in the NPX group (P = 0.077).
DISCUSSION
The predominant type of RPS developing in the perirenal space is LPS originating from perirenal fat. LPS is likely to be indistinguishable from perirenal fat tissue, and surgeons may find it difficult to confirm involvement of the renal parenchyma in the operative field. For this reason, surgeons usually perform en bloc nephrectomy for cases of RPS with kidney encasement to guarantee complete macroscopic resection. However, some surgeons are reluctant to conduct simultaneous resection of kidneys encased by RPS because there is limited evidence regarding the oncological benefit of en bloc nephrectomy 4 and the long-term risk of CKD in patients following nephrectomy. 7 To address these two questions, we performed comparative analysis of postoperative kidney function and long-term oncological outcomes in the same cohort of 114 patients classified into NPX (n = 65) and no NPX (n = 49) groups.
Compared to the postoperative renal function of the no-NPX group, NPX patients had statistically significant decreases in Δ change e468 CHO ET AL. and % change between pre and postoperative ultimate GFR. The NPX group had the lowest and highest GFR measurements at a median of 2 and 4 days after nephrectomy, respectively, but renal function stabilized within 6 weeks postnephrectomy. This tendency curve reflects the routine course of renal adaptation after nephrectomy, similar to previous studies of donor nephrectomy 15 and partial nephrectomy. 8 After nephrectomy, renal adaptation and residual kidney function have been well-established in a study regarding patients who underwent donor nephrectomy. Generally, after kidney donation, there is an initial decline in GFR of 25-35%. This is followed by a small increase in GFR, which is then maintained at 60-75% of prenephrectomy GFR. 14 There might be some controversy, but we compared kidney function changes after RPS surgery including nephrectomy with the result after donor nephrectomy in order to explain renal adaptation after unilateral nephrectomy. There were 65 patients who underwent nephrectomy that showed a 26.5% reduction of preoperative GFR during a follow-up period of over 2 years. However, this result does not completely reflect our study since some patients received nephrotoxic NPX group might be larger than those in no-NPX group. Since this selection bias was inevitable to perform this small retrospective study, we did not adjust for tumor size. This is a drawback of this study.
TA B L E 1 General characteristics of patients undergoing surgery with or without nephrectomy for primary retroperitoneal sarcoma (RPS)
Characteristics
However, Keung et al. reported that predictors affecting outcomes in RPS were tumor integrity (intact vs fragmented), multifocality, macroscopic completeness and FNCLCC grade. 17 Unlike extremity sarcoma, tumor size was not a prognostic factor. In our study, although there was a difference in tumor size between two groups, FNCLCC grade and macroscopic complete resection were not different between the two groups.
It is well known that an aggressive surgical strategy improves local control of RPS. 4, 18 However, there is insufficient evidence regarding RPS located in the perirenal space to ensure that en bloc nephrectomy improves long-term survival and locoregional tumor control.
Our study demonstrated that the trend toward better local control for patients who underwent en bloc nephrectomy was more pro- Conversely, the number of grade 3 patients was not sufficient to evaluate the survival difference between the NPX and no-NPX groups, as mentioned above.
Our study has several limitations. First, the follow-up duration for renal function was not enough to confirm long-term outcomes of kidney function after nephrectomy due to recently starting routine laboratory check-ups of blood chemistry at the outpatient clinic. The second limitation is that our study consisted of a small cohort, especially for FNCLCC grade 3 patients. We will report the kidney function change and oncological outcomes after en bloc nephrectomy for RPS with larger populations and longer follow-up in a subsequent study.
The third limitation is comparing kidney function changes after RPS surgery including nephrectomy with results after donor nephrectomy.
Finally, more patients in the NPX group underwent RT compared with no-NPX patients.
In conclusion, kidney function changes after en bloc nephrectomy for RPS may be acceptable because no patient progressed to ESRD, required dialysis or had systemic treatment limitations despite the progression of CKD stage. Although a larger cohort of RPS patients is necessary to definitely confirm these oncological outcomes, an aggressive surgical approach including nephrectomy for perinephric RPS enables complete macroscopic resection and improves local tumor control and survival. Therefore, when surgeons encounter RPS abutting the kidney, en bloc nephrectomy may be helpful to obtain complete resection margins.
